Mode
Text Size
Log in / Sign up

Thymoma

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Thymoma

7 trials tracked for Thymoma.

7Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 7
  1. Phase 2 Sunitinib for Advanced Thymus Cancer Following Earlier Treatment Completed
  2. Phase 2 Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma Completed
  3. Phase 2 A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas Completed
  4. Phase 2 Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy Completed
  5. Phase 2 Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma Completed
  6. Phase 2 Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage Completed
Show 1 more trials
  1. Phase 2 A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.